FIRST LIGHT ASSET MANAGEMENT LLC
Q3 2024 Form 13-F

EDINA, MINNESOTA
CIK 0001600004 · CRD 168899 · SEC-registered investment adviser
$1.2B Reported Value Total

FIRST LIGHT ASSET MANAGEMENT, LLC reports 1,165 total accounts under management (AUM). There are 1,165 discretionary accounts valued at $1,387,863,426, and 0 non-discretionary accounts.

Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
SEC Registered Discretionary Manager
Private funds (Form ADV)
4 funds · $1.1B gross asset value
Hedge Fund: $1.1B
Source: Form ADV filed 2026-03-24
Reported value
$1.2B
Quarter over quarter
+14.5%
Holdings
38
Top-10 concentration
47.7%

Filing Structure

Holdings reported by

Key People

Form ADV owners & control persons
Mathew Paul Arens
MANAGING MEMBER, CEO, & SENIOR PORTFOLIO MANAGER
Brett Thomas Johnson
SENIOR RESEARCH ANALYST & FOUNDING PRINCIPAL
Kurt Terry Peterson
CHIEF FINANCIAL OFFICER & CHIEF COMPLIANCE OFFICER

Filing Navigation

13F Metrics

Loading 13F Metrics

Q3 2024 13F record

Q3 2024 13F filing summary

Q3 2024 Form 13F portfolio summary
Period of report September 30, 2024
Filed November 14, 2024
Form 13F-HR
Reported value $1.2B
Positions 38
Change in reported value +5.4%
New positions 5
Exited positions 11
Position turnover 32.7%
Top-10 concentration 47.7%

13F filings by quarter

Form 13F filings by quarter
Quarter Positions Value
Q3 2026 13F
Filed Nov 16, 2026
32 $1.7B
Q2 2026 13F
Filed Aug 14, 2026
31 $1.6B
Q1 2026 13F
Filed May 15, 2026
35 $1.1B
Q4 2025 13F
Filed Feb 17, 2026
33 $1.3B
Q3 2025 13F
Filed Nov 14, 2025
41 $1.1B
Q2 2025 13F
Filed Aug 14, 2025
38 $771.3M
Q1 2025 13F
Filed May 15, 2025
37 $875.7M
Q4 2024 13F
Filed Feb 14, 2025
36 $1.0B
Q3 2024 13F
Filed Nov 14, 2024
38 $1.2B
Q2 2024 13F
Filed Aug 14, 2024
44 $1.1B
Q1 2024 13F
Filed May 15, 2024
50 $1.3B
Q4 2023 13F
Filed Feb 14, 2024
75 $1.2B
Q3 2023 13F
Filed Nov 14, 2023
75 $1.1B
Q2 2023 13F
Filed Aug 14, 2023
79 $1.3B
Q1 2023 13F
Filed May 15, 2023
74 $1.1B
Q4 2022 13F
Filed Feb 14, 2023
74 $1.1B
Q3 2022 13F
Filed Nov 14, 2022
71 $988.1M
Q2 2022 13F
Filed Aug 12, 2022
71 $859.4M
Q1 2022 13F
Filed May 13, 2022
75 $1.1B
Q4 2021 13F
Filed Feb 14, 2022
79 $1.4B

32 earlier quarters on file — choose one from the quarter menu above.

Top 20 holdings · Q3 2024

Largest Q3 2024 13F positions by reported value
# Holding Reported value % of portfolio
1 CNTA CENTESSA PHARMACEUTICALS LIMITED $95.0M 7.9%
2 FNA PARAGON 28 INC $67.8M 5.64%
3 EVH EVOLENT HEALTH INC $65.0M 5.41%
4 AXGN AXOGEN INC $57.3M 4.77%
5 ATRC ATRICURE INC $52.3M 4.35%
6 INSM INSMED INC $50.3M 4.18%
7 CRNX CRINETICS PHARMACEUTICALS INC $48.2M 4.01%
8 XENE XENON PHARMACEUTICALS $46.5M 3.87%
9 NEO NEOGENOMICS INC $45.4M 3.78%
10 DYN DYNE THERAPEUTICS INC $45.2M 3.76%
11 TNDM TANDEM DIABETES CARE INC $43.5M 3.62%
12 RARE ULTRAGENYX PHARMACEUTICAL INC $41.9M 3.49%
13 PFMT PERFORMANT FINANCIAL CORPORATION $41.9M 3.49%
14 TMDX TRANSMEDICS GROUP INC $41.7M 3.47%
15 OSCR OSCAR HEALTH INC CLASS A $37.5M 3.12%
16 PODD INSULET CORP $37.0M 3.08%
17 HCAT HEALTH CATALYST INC $35.0M 2.91%
18 ANAB ANAPTYS BIO INC $31.8M 2.64%
19 CDMO AVID BIOSERVICES INC $31.5M 2.62%
20 VERA VERA THERAPEUTICS INC $31.2M 2.59%

Values as reported on the Q3 2024 Form 13F. Every position is in the holdings table below.

Filing Details

Loading Activities
Loading Sector Allocation
Crunching numbers

Performance

Loading Performance

Potential New Buys

Finding Potential New Buys

Holdings

Building table
Loading SEC filing data
Loading Form 4 Filings

Beneficial Ownership (Schedule 13D/13G)

Loading 13D/G filings